Published in Hepatitis Weekly, December 19th, 2011
"Seventy-five consecutive patients who failed to IFN alpha-based therapy were retreated with peginterferon plus ribavirin. Of these patients, 85% were infected by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.